Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 49 articles:
HTML format
Text format



Single Articles


    November 2018
  1. HU YB, Yan C, Mu L, Mi YL, et al
    Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.
    Oncogene. 2018 Nov 2. pii: 10.1038/s41388-018-0557.
    PubMed     Text format     Abstract available


    October 2018
  2. WAGNER S, Vlachogiannis G, De Haven Brandon A, Valenti M, et al
    Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.
    Oncogene. 2018 Oct 23. pii: 10.1038/s41388-018-0554.
    PubMed     Text format     Abstract available


  3. WEI N, Li J, Fang C, Chang J, et al
    Targeting colon cancer with the novel STAT3 inhibitor bruceantinol.
    Oncogene. 2018 Oct 22. pii: 10.1038/s41388-018-0547.
    PubMed     Text format     Abstract available


    September 2018
  4. ARBEL RUBINSTEIN T, Shahmoon S, Zigmond E, Etan T, et al
    Klotho suppresses colorectal cancer through modulation of the unfolded protein response.
    Oncogene. 2018 Sep 19. pii: 10.1038/s41388-018-0489.
    PubMed     Text format     Abstract available


  5. ZHAO L, Zhang D, Shen Q, Jin M, et al
    KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway.
    Oncogene. 2018 Sep 10. pii: 10.1038/s41388-018-0493.
    PubMed     Text format     Abstract available


  6. NAKANO M, Kikushige Y, Miyawaki K, Kunisaki Y, et al
    Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer.
    Oncogene. 2018 Sep 4. pii: 10.1038/s41388-018-0480.
    PubMed     Text format     Abstract available


    August 2018
  7. LI Q, Wei P, Wu J, Zhang M, et al
    The FOXC1/FBP1 signaling axis promotes colorectal cancer proliferation by enhancing the Warburg effect.
    Oncogene. 2018 Aug 31. pii: 10.1038/s41388-018-0469.
    PubMed     Text format     Abstract available


  8. JIANG M, Xu B, Li X, Shang Y, et al
    O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit.
    Oncogene. 2018 Aug 9. pii: 10.1038/s41388-018-0435.
    PubMed     Text format     Abstract available


  9. HE F, Song Z, Chen H, Chen Z, et al
    Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128.
    Oncogene. 2018 Aug 3. pii: 10.1038/s41388-018-0432.
    PubMed     Text format     Abstract available


    July 2018
  10. WANG YN, Zeng ZL, Lu J, Wang Y, et al
    CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis.
    Oncogene. 2018 Jul 11. pii: 10.1038/s41388-018-0384.
    PubMed     Text format     Abstract available


    June 2018
  11. ZENG K, Chen X, Hu X, Liu X, et al
    LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
    Oncogene. 2018 Jun 13. pii: 10.1038/s41388-018-0352.
    PubMed     Text format     Abstract available


  12. LEE H, Kim N, Yoo YJ, Kim H, et al
    beta-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer.
    Oncogene. 2018 Jun 12. pii: 10.1038/s41388-018-0362.
    PubMed     Text format     Abstract available


  13. LIU J, Zhang Z, Li X, Chen J, et al
    Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression.
    Oncogene. 2018 Jun 8. pii: 10.1038/s41388-018-0355.
    PubMed     Text format     Abstract available


    May 2018
  14. KNICKELBEIN K, Tong J, Chen D, Wang YJ, et al
    Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer.
    Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0289.
    PubMed     Text format     Abstract available


    April 2018
  15. COANT N, Garcia-Barros M, Zhang Q, Obeid LM, et al
    AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells.
    Oncogene. 2018 Apr 17. pii: 10.1038/s41388-018-0236.
    PubMed     Text format     Abstract available


  16. JUNG JH, Jung DB, Kim H, Lee H, et al
    Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3beta and F-box and WD repeat domain-containing 7.
    Oncogene. 2018 Apr 9. pii: 10.1038/s41388-018-0225.
    PubMed     Text format     Abstract available


    March 2018
  17. ZHANG Y, Wang S, Kang W, Liu C, et al
    CREPT facilitates colorectal cancer growth through inducing Wnt/beta-catenin pathway by enhancing p300-mediated beta-catenin acetylation.
    Oncogene. 2018 Mar 22. pii: 10.1038/s41388-018-0161.
    PubMed     Text format     Abstract available


  18. CHU PC, Lin PC, Wu HY, Lin KT, et al
    Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
    Oncogene. 2018 Mar 21. pii: 10.1038/s41388-018-0222.
    PubMed     Text format     Abstract available


  19. SAPONARO C, Sergio S, Coluccia A, De Luca M, et al
    beta-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy.
    Oncogene. 2018 Mar 19. pii: 10.1038/s41388-018-0170.
    PubMed     Text format     Abstract available


  20. TANG J, Chen H, Wong CC, Liu D, et al
    DEAD-box helicase 27 promotes colorectal cancer growth and metastasis and predicts poor survival in CRC patients.
    Oncogene. 2018 Mar 14. pii: 10.1038/s41388-018-0196.
    PubMed     Text format     Abstract available


    February 2018
  21. ROMANO G, Chagani S, Kwong LN
    The path to metastatic mouse models of colorectal cancer.
    Oncogene. 2018 Feb 21. pii: 10.1038/s41388-018-0155.
    PubMed     Text format     Abstract available


  22. DI RUOCCO F, Basso V, Rivoire M, Mehlen P, et al
    Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression.
    Oncogene. 2018;37:627-637.
    PubMed     Text format     Abstract available


    January 2018
  23. SHEN L, Qu X, Li H, Xu C, et al
    NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis.
    Oncogene. 2018 Jan 18. pii: 10.1038/s41388-017-0118.
    PubMed     Text format     Abstract available


  24. SOLOMON H, Dinowitz N, Pateras IS, Cooks T, et al
    Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.
    Oncogene. 2018 Jan 18. pii: 10.1038/s41388-017-0060.
    PubMed     Text format     Abstract available


  25. HERR R, Halbach S, Heizmann M, Busch H, et al
    BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines.
    Oncogene. 2018 Jan 12. pii: 10.1038/s41388-017-0063.
    PubMed     Text format     Abstract available


  26. LIU L, Luo C, Luo Y, Chen L, et al
    MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression.
    Oncogene. 2018;37:86-94.
    PubMed     Text format     Abstract available


  27. CHANDRASINGHE P, Cereser B, Moorghen M, Al Bakir I, et al
    Role of SMAD proteins in colitis-associated cancer: from known to the unknown.
    Oncogene. 2018;37:1-7.
    PubMed     Text format     Abstract available


  28. SONG C, Liang L, Jin Y, Li Y, et al
    RCC2 is a novel p53 target in suppressing metastasis.
    Oncogene. 2018;37:8-17.
    PubMed     Text format     Abstract available


  29. DIEHL K, Dinges LA, Helm O, Ammar N, et al
    Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.
    Oncogene. 2018;37:39-51.
    PubMed     Text format     Abstract available


    December 2017
  30. OMOTO T, Kim-Kaneyama JR, Lei XF, Orimo A, et al
    The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodeling.
    Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0033.
    PubMed     Text format     Abstract available


  31. BLOMME A, Van Simaeys G, Doumont G, Costanza B, et al
    Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases.
    Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0018.
    PubMed     Text format     Abstract available


  32. LEE SH, Yu J, Hwang GH, Kim S, et al
    CUT-PCR: CRISPR-mediated, ultrasensitive detection of target DNA using PCR.
    Oncogene. 2017;36:6823-6829.
    PubMed     Text format     Abstract available


    November 2017
  33. HATA AN, Rowley S, Archibald HL, Gomez-Caraballo M, et al
    Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers.
    Oncogene. 2017;36:6581-6591.
    PubMed     Text format     Abstract available


  34. LEE JH, Han YS, Yoon YM, Yun CW, et al
    Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1alpha/GP78 axis.
    Oncogene. 2017;36:6555-6567.
    PubMed     Text format     Abstract available


  35. WANG Q, Zhu J, Wang YW, Dai Y, et al
    Tumor suppressor Pdcd4 attenuates Sin1 translation to inhibit invasion in colon carcinoma.
    Oncogene. 2017;36:6225-6234.
    PubMed     Text format     Abstract available


  36. TRINIDAD AG, Whalley N, Rowlinson R, Delpuech O, et al
    Pyruvate dehydrogenase kinase 4 exhibits a novel role in the activation of mutant KRAS, regulating cell growth in lung and colorectal tumour cells.
    Oncogene. 2017;36:6164-6176.
    PubMed     Text format     Abstract available


    October 2017
  37. SCHROYER AL, Stimes NW, Abi Saab WF, Chadee DN, et al
    MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells.
    Oncogene. 2017 Oct 30. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  38. BENTHANI FA, Herrmann D, Tran PN, Pangon L, et al
    'MCC' protein interacts with E-cadherin and beta-catenin strengthening cell-cell adhesion of HCT116 colon cancer cells.
    Oncogene. 2017 Oct 16. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  39. WEISENBERGER DJ, Liang G, Lenz HJ
    DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  40. WANG LF, Liu YS, Yang B, Li P, et al
    The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    September 2017
  41. FU LN, Wang YQ, Tan J, Xu J, et al
    Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  42. LIU L, Wong CC, Gong B, Yu J, et al
    Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    August 2017
  43. WANG X, Haring MF, Rathjen T, Lockhart SM, et al
    Insulin resistance in vascular endothelial cells promotes intestinal tumour formation.
    Oncogene. 2017;36:4987-4996.
    PubMed     Text format     Abstract available


  44. HANLEY MP, Hahn MA, Li AX, Wu X, et al
    Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia.
    Oncogene. 2017;36:5035-5044.
    PubMed     Text format     Abstract available


  45. SUMNER ET, Chawla AT, Cororaton AD, Koblinski JE, et al
    Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasia.
    Oncogene. 2017;36:4810-4816.
    PubMed     Text format     Abstract available


    July 2017
  46. MA X, Meng Z, Jin L, Xiao Z, et al
    CAMK2gamma in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation.
    Oncogene. 2017;36:4060-4071.
    PubMed     Text format     Abstract available


  47. HARDBOWER DM, Coburn LA, Asim M, Singh K, et al
    EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis.
    Oncogene. 2017;36:3807-3819.
    PubMed     Text format     Abstract available


    June 2017
  48. LI Y, Zhou T, Wang Y, Ning C, et al
    The protumorigenic potential of FTY720 by promoting extramedullary hematopoiesis and MDSC accumulation.
    Oncogene. 2017;36:3760-3771.
    PubMed     Text format     Abstract available


  49. ROS S, Floter J, Kaymak I, Da Costa C, et al
    6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.
    Oncogene. 2017;36:3287-3299.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: